BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18518899)

  • 1. p63 expression in ovarian tumours: immunopositivity in metastatic transitional cell carcinoma of the ovary.
    Kalebi A; Hale M
    Histopathology; 2008 Aug; 53(2):228. PubMed ID: 18518899
    [No Abstract]   [Full Text] [Related]  

  • 2. p63 gene expression study and early bladder carcinogenesis.
    Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
    Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
    Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
    Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated transitional cell carcinoma versus leiomyosarcoma of the ureter: different defects in tumour suppressor genes.
    Tzen CY; Wu CJ; Huang ZD; Wu TY
    Histopathology; 2007 Aug; 51(2):271-3. PubMed ID: 17593211
    [No Abstract]   [Full Text] [Related]  

  • 5. Bladder cancer discovered by ovarian metastasis: cytokeratin expression is useful when making differential diagnosis.
    Ishii Y; Itoh N; Takahashi A; Masumori N; Ikeda T; Tsukamoto T
    Int J Urol; 2005 Jan; 12(1):104-7. PubMed ID: 15661064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krukenberg tumor of renal pelvic origin: report of a case with selected comments on ovarian tumors metastatic from the urinary tract.
    Irving JA; Vasques DR; McGuinness TB; Young RH
    Int J Gynecol Pathol; 2006 Apr; 25(2):147-50. PubMed ID: 16633063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment on: immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Papatsoris A; Deliveliotis C
    Eur Urol; 2008 May; 53(5):1073. PubMed ID: 17980953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
    Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
    Esheba GE; Longacre TA; Atkins KA; Higgins JP
    Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p63 in thymomas and normal thymus.
    Dotto J; Pelosi G; Rosai J
    Am J Clin Pathol; 2007 Mar; 127(3):415-20. PubMed ID: 17276940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitional cell carcinomas in the bladder and ovary: unusual primary association or metastatic lesions?
    Kadiri H; Jahid A; Zouaidia F; Sbitti Y; Ismaili N; Errihani H; Bernoussi Z; Mahassini N
    Taiwan J Obstet Gynecol; 2010 Sep; 49(3):373-6. PubMed ID: 21056329
    [No Abstract]   [Full Text] [Related]  

  • 13. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
    Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell tumors of the ovary: a compact group with a heterogeneous histological and immunophenotypical pattern.
    Ceauşu M; Terzea D; Georgescu A; Dobrea C; Mihai M; Iosif C; Vasilescu F; Ardeleanu C
    Rom J Morphol Embryol; 2008; 49(4):513-6. PubMed ID: 19050800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired delta NP63 expression is associated with poor tumor development in transitional cell carcinoma of the bladder.
    He Y; Wu X; Tang W; Tian D; Luo C; Yin Z; Du H
    J Korean Med Sci; 2008 Oct; 23(5):825-32. PubMed ID: 18955789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p63 expression correlates with pathological features and biological behaviour of odontogenic tumours.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Giannone N; Carinci F; Leonardi R; Lanzafame S; Piattelli A
    Histopathology; 2006 Aug; 49(2):211-4. PubMed ID: 16879406
    [No Abstract]   [Full Text] [Related]  

  • 17. Transitional cell carcinoma of the ovary: unusual presentation as metastatic cervical lymph node.
    Keepanasseril A; Suri V; Gupta N; Ghoshal S
    J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):696-8. PubMed ID: 18840184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
    Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry of p63 in primary and secondary vulvar Paget's disease.
    Yanai H; Takahashi N; Omori M; Oda W; Yamadori I; Takada S; Matsuura H; Yoshino T
    Pathol Int; 2008 Oct; 58(10):648-51. PubMed ID: 18801085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.